A new type of hazardous chemical: The chemosensitizers of multixenobiotic resistance

Environmental Health Perspectives

Volumn 105, Issue SUPPL. 4, 1997, Pages 855-860

  Kurelec, Branko ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Aquatic organisms; Chemosensitizers; Determination of; Induction; Inhibition; Multixenobiotic resistance; P170 glycoprotein

Indexed keywords

XENOBIOTIC AGENT;

AQUATIC FAUNA; BIOACCUMULATION; CHEMOSENSITIVITY; CONFERENCE PAPER; DANGEROUS GOODS; ENVIRONMENTAL EXPOSURE; PRIORITY JOURNAL; TOXICITY; WATER POLLUTANT;

EID: 0030821662     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.97105s4855     Document Type: Conference Paper

References (74)

1. Kurelec B. The multixenobiotic resistance mechanism in aquatic organisms. Crit Rev Toxicol 22:23-43 (1992).
2. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152-162 (1976).
3. Morrow CS, Cowan KH. Mechanisms and clinical significance of multidrug resistance. Oncology 2:55-66 (1988).
4. Horio M, Gottesman MM, Pastan I. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc Natl Acad Sci USA 85:3580-3584 (1988).
5. Ueda K, Cornwell MM, Gottesman M, Pastan I, Roninson I, Ling V, Riordan JR. The mdr1 gene, responsible for multidrug-resistance, codes for the p-glycoprotein. Biochem Biophys Res Commun 141:956-962 (1986).
6. Shen DW, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I, Gottesman MM. Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science 232:643-645 (1986).
7. Endicott JA, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58:137-171 (1989).
8. Yusa K, Tsuruo T. Reversal mechanism of multidrug resistance by verapamil to P-glycoprotein on specific sites and transport of verapamil outwards across the plasma membrane of K562/ADM cells. Cancer Res 49:5002-5006 (1989).
9. Center MS. Mechanisms regulating cell resistance to adriamycin: evidence that drug accumulation in resistant cells is modulated by phosphorylation of a plasma membrane glycoprotein. Biochem Pharmacol 34:1471-1476 (1985).
10. Chambers TC, Chalikonda I, Eilon G. Correlation of protein kinase C translocation, P-glycoprotein phosphorylation and reduced drug accumulation in multidrug resistant human KB cells. Biochem Biophys Res Commun 169:253-259 (1990).
11. Ma L, Marquardt D, Takemoto L, Center MS. Analysis of P-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine. J Biol Chem 266:5593-5599 (1991).
12. Kurelec B, Pivceviac B. Distinct glutathione-dependent enzyme activities and a verapamil sensitive binding of xenobiotics in a fresh-water mussel Anodonta cygnea. Biochem Biophys Res Commun 164:934-940 (1989).
13. Waldmann P, Pivceviac B, Mueller WEG, Zahn RK, Kurelec B. Increased genotoxicity of aminoanthracene by modulators of multixenobiotic resistance mechanism: studies with the fresh water clam Corbicula fluminea. Mutat Res 342:113-123 (1993).
14. Kurelec B, Pivceviac, B. Evidence for a multixenobiotic resistance mechanism in the mussel Mytilus galloprovincialis. Aquatic Toxicol 19:291-302 (1991).
15. Kurelec B, Pivceviac B. The multidrug resistance-like mehanism in a marine sponge Tethya aurantium. Marine Environ Res 34:249-253 (1992).
16. Mueller WEG, Stefen R, Rinkevich B, Matranga V, Kurelec B. Multixenobiotic resistance mechanism in plasma membranes of cells from the marine sponge Suberites domuncula: its potential application in assessment of environmental pollution. Marine Biol 125:169-170 (1996).
17. Kurelec B, Krca S, Pivceviac B, Ugarkoviac, Bachmann M, Imsiecke G, Mueller WEG. Expression of P-glycoprotein gene in marine sponges. Identification and characterization of the 125-kDa drug-binding glycoprotein. Carcinogenesis 13:69-76 (1992).
18. Holland-Toomey B, Epel D. Multixenobiotic resistance in Urechis embrios: protection from environmental toxins. Biol Bull 185:355-386 (1993).
19. Minier C, Akcha F, Galgani F. P-glycoprotein expression in Crassostrea gigas and Mytilus edulis in polluted seawater. Comp Biochem Physiol 106B:1029-1036 (1993).
20. Moore M. Cellular and molecular biology and pathology. In Plymouth Marine Laboratory Report 1991-1992. Plymouth UK:Plymouth Marine Laboratory, 1992;45-46.
21. Smital T, Pivceviac B, Kurelec B. Excretory product from tropical marine alga Caulerpa taxifolia inhibit a basic defence mechanism in competing organisms. 1st Croatian Congress of Toxicology, 17-19 April 1996 Zagreb. Abstract Book, 1996.
22. Wilson WR, Serrano AE, Wasley A, Bogenschutz MP, Shankar AH, Wirth DF. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 244:1184-1186 (1989).
23. Foote SJ, Kyle DE., Martin RK, Oduola AMJ, Forsyth K, Kemp DJ, Cowman AF. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345: 255-258 (1990).
24. Henderson DM, Sifri CD, Rodgers M, Wirth DF, Hendrickson N, Ullman B. Multidrug resistance in Leishmania donovani is conferred by amplification of a gene homologous to the mammalian mdr1 gene. Mol Cell Biol 12:2855-2865 (1992).
25. McGrath JP, Varshavsky A. The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein. Nature 340:400-404 (1989).
26. Hussain M, Lenard J. Characterization of PDR4, a Saccharomyces cerevisie gene that confers pleiotropic drug resistance in high-copy number. Gene 101:149-152 (1991).
27. Neyfakh AA, Bidnenko VE, Chen LB. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system. Proc Natl Acad Sci USA 88:4781-4785 (1991).
28. Neyfakh AA. The multidrug efflux transporter of Bacilus subtilis is a structural and functional homolog of the Staphylococcus nor A protein. Antimicrob Agents Chemotherapy 36:484-485 (1992).
29. Ferguson LR, Baguley BC. Multidrug resistance and mutagenesis. Mutat Res 285:79-90 (1993).
30. Miyauchi S, Komatsubara M, Kamo N. In archaebacteria, there is a doxorubicin efflux pump similar to mammalian P-glycoprotein. Biochim Biophys Acta 1110:144-150 (1992).
31. Wu CT, Budding MS, Griffin MS, Croop JM. Isolation and characterization of Drosophila multidrug resistance gene homologs. Mol Cell Biol 11:3940-3948 (1991).
32. Broeks A, Janssen HWRM, Calafat J, Plasterk RHA. A P-glycoprotein protects Caenorhabditis elegans against natural toxins. EMBO J 14:1858-1866 (1995).
33. Chan KM, Davies PL, Childs S, Veinot S, Ling V. P-glycoprotein genes in the winter flounder, Pseudopleuronectes americanus: isolation of two types of genomic clones carrying 3′ terminal exons. Biochim Biophys Acta 1171:65-72 (1992).
34. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7735-7738 (1987).
35. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86:695-698 (1989).
36. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385-427 (1993).
37. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R Human P-glycoprotein transports cortisol, aldosterone, and dexamethazone, but not progesterone. J Biol Chem 267:24248-24252 (1992).
38. Thorgeirsson SS, Huber BE, Sorrell S, Fojo A, Pastan I, Gottesman MM. Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. Science 236:1120-1121 (1987).
39. Fairchild CR, Ivy SP, Rushmore T, Koo P, Goldsmith ME et al. Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proc Natl Acad Sci USA 84:7701-7705 (1987).
40. Burt RK, Thorgeirsson SS. Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics. J Natl Cancer Inst 80:1383-386 (1988).
41. Gant TW, Silverman JA, Bisgaard HC, Burt RK, Marino PA, Thorgeirsson, SS. Regulation of 2-acetylamonofluorene mediated and 3-methylcholanthrene mediated induction of multidrug resistance and cytochrome-P4501A gene family expression in primary hepatocyte cultures and rat liver. Mol Carcinog 4:499-509 (1991).
42. Moscow JA, Cossman J, Myers CE, Cowan K. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res 49:1422-1428 (1989).
43. Chin KV, Tanaka S, Darlington G, Pastan I , Gottesman MM. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J Biol Chem 265:221-226 (1990).
44. Kioka N, Yamano Y , Komano T, Ueda K. Heat shock responsive elements in the induction of the multidrug resistance gene (MDR1). FEBS Lett 301:37-40 (1992).
45. Graham-Bryce IJ. Resistance to pesticides and antibiotics: how far is it comprehensible and manageable?. In: Combating Resistance to Xenobiotics: Biological and Chemical Approaches (Ford MG, Holloman DW, Khanbay BPS, Sawicki RM, eds). Chichester, UK:Ellis Horwood, 1987;11-25.
46. Kurelec B, Luciac D, Pivceviac B, Krca S. Induction and reversion of multixenobiotic resistance in the marine snail Monodonta turbinata. Marine Biol.123:305-312 (1995).
47. Kurelec B, Krca S. Luciac D. Expression of multixenobiotic resistance mechanism in a marine mussel Mytilus galloprovincialis as a biomarker of exposure to polluted environment. Comp Biochem Physiol, 113C:283-289 (1996).
48. Kurelec B. Reversion of the multixenobiotic resistance mechenism in gills of a marine mussel Mytilus galloprovincialis by a model inhibitor and environmental modulators of P170-glycoprotein. Aquatic Toxicol 3:93-103 (1995).
49. Kurelec B, Pivceviac B, Müller WEG. Determination of pollutants with multixenobiotic resistance inhibiting properties. Mar Environ Res 39:261-265 (1995).
50. 32P-postlabeling: relationships to cancer and aging. Exp Gerontol 27:533-549 (1992).
51. Kurelec B, Garg A, Krca S, Chacko M, Gupta RC. Natural environment surpasses polluted environment in inducing DNA damage in fish. Carcinogenesis 10:1337-1339 (1989).
52. Garg A, Krca S, Kurelec B, Gupta RC. Endogenous DNA modifications in aquatic organisms and their probable biological significance. Comp Biochem Physiol 102B:825-832 (1992).
53. Kurelec B, Gupta, RC. Biomonitoring of aquatic systems. In: Postlabelling Methods for Detection of DNA Adducts (Phillips DH, Castegnaro M, Bartsch H, eds). IARC Scientific Publications No. 224. Lyon:International Agency for Research on Cancer, 1993;365-372.
54. Tsuruo T, Iida H, Tsukagoshi S, Sukurai Y. Overcoming of vincristine resistance in P388 leukemia, in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967-1972 (1981).
55. Ford JM, Hait WN. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 4:155-199 (1990).
56. Mechetner EB, Roninson IB. Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Proc Natl Acad Sci USA 89:5824-5828 (1992).
57. Nogae I, Kohno K, Kikuchi J, Kuwano M, Akiyama SI, Kiue A, Suzuki KI, Yoshida Y, Cornwell M M , Pastan I. Analysis of structural features of dohydropyridine analogs needed to reverse multidrug resistance and to inhibit photolabeling of P-glycoprotein. Biochem Pharmacol 38:519-527 (1989).
58. Hofsli E, Nissen-Meyer J. Reversal of multidrug resistance by lipophilic drugs. Cancer Res 50:3997-4002 (1990).
59. Klopman G, Srivasta S, Kolossvary I, Epand RF, Ahmed N, Epand RM. Structure activity study and design of multidrug-resistant reversal compounds by a computer automated structure evaluation methodology. Cancer Res 52:4121-4129 (1992).
60. Smith CD, Prinsep MR, Caplan FR, Moore RE, Patterson M.L. Reversal of multiple drug resistance by tolyporphin, a novel cyanobacterial natural product. Oncology Res 6:211-218 (1994).
61. Ikeda S, Sugita M, Yoshimura A, Sumizawa T, Douzono H, Nagata Y, Akiyama S. Aspergilus species strain M39 produces two naphtho-γ-pyrones that reverse drug resistance in human KB cells. Intl J Cancer 45:508-513 (1990).
62. Williams AB, Jacobs RS. A marine natural product, patellamide D, reverses multidrug resistance in a human leukemic cell line. Cancer Lett 71:97-102 (1993).
63. Sato W, Fukazawa N, Suzuki T, Yusa K, Tsuruo T. Circumvention of multidrug resistance by a newly synthesised quinoline derivative, MS-073. Cancer Res 51:2420-2424 (1991).
64. Miller TP, Grogan TM, Dalton WS, Spier CM, Schaper RJ, Salmon SE. P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high doseverapamil. J Clin Oncol 9:17-24 (1989).
65. Hofsli E, Nissen-Meyer J. Reversal of multidrug resistance by lipophilic drugs. Cancer Res 50:3997-4002 (1990).
66. Yoshimura A, Shudo N., Ikeda S, Ichikawa M, Sumizawa T, Akiyama SI. Novel screening method for agents that overcome classical multidrug resistance in a human cell line. Cancer Lett 50:45-51 (1990).
67. Homolya L, Hollo Z, Germann U, Pastan I, Gottesman MM, Sarkadi B. Fluorescent cellular indicators are extruded by the multidrug resistance protein. J Biol Chem 268:21493-21496 (1993).
68. Hollo Z, Homolya L, Davis CW, Sarkadi B. Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochim Biophys Acta 1191:384-388 (1994).
69. Sarkadi B, Price E.M, Bouchers RC, Germann UA, Scarborough GA. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J Biol Chem 267:4854-4858 (1992).
70. Sarkadi B, Mueller M, Homolya L, Hollo Z, Seprodi J, Germann U, Gottesman MM, Price EM, Boucher RC. Interaction of bioactive hydrophobic peptides with the human multidrug transporter. FASEB J 8:766-770 (1994).
71. Slooff W, Van Oers JA, De Zwart D. Margins of uncertainty in ecotoxicological hazard-assessement. Environ Toxicol Chem 5:841-852 (1986).
72. Britviac S, Beadini N, Luciac D, Kurelec B. Fluorescence of fish bile as indicator of pollution by xenobiotics. SECOTQX Regional Meeting, 26-29 September 1993, Rome. Abstract Book, 133.
73. Kurelec B, Pivcevic B, Smital T. Unpublished data.
74. Smital T, Pivcevic B, Kurelec B. Reversal of multidrug resistance by extract from a marine algea Caulerpa taxifolia. Period Biol 98:165-171 (1996).